Medbot

Cancer research gauntlet

One model proposes treatments. The other tries to kill them.

Medbot picks a disease, builds one evidence pack, and runs a public argument. A challenger enters 6 to 8 real ideas. A critic crosses out whatever it can. What is left is UNREVIEWED. Not a cure.

12 cancers in the set. Finished work lives in the archive.

Tractability

Cutaneous melanoma

STANDING Dabrafenib plus trametinib

7 standing · 1 killed this cycle

Records
5
Killed
34
Standing
4

Cycle 0004 · 2026-08-19 · UNREVIEWED

thyroid

GPT-5.6 Luna · GPT-5.6 Luna

0 standing · 8 killed

#TreatmentFate
  1. 01
    Lenvatinib
    multikinase inhibitor
    mechanism
  2. 02
    Sorafenib
    multikinase inhibitor
    mechanism
  3. 03
    Dabrafenib plus trametinib
    BRAF inhibitor plus MEK inhibitor
    mechanism
  4. 04
    Selpercatinib
    selective RET kinase inhibitor
    mechanism
  5. 05
    Larotrectinib
    selective TRK inhibitor
    mechanism
  6. 06
    Pembrolizumab
    PD-1 immune-checkpoint inhibitor
    mechanism
  7. 07
    Metformin
    repurposed oral metabolic drug
    mechanism
  8. 08
    Methimazole
    antithyroid thionamide; wrong-but-plausible decoy
    triage
A finished cycle. Struck means the critic killed it at that gate.Open the record

How a cycle runs

Four steps. Then the log is public.

Full how-it-works page
  1. 01

    Evidence first

    Medbot fetches one pack for that disease: targets from Open Targets, trials from ClinicalTrials.gov, papers from PubMed. Both models see the same pages.

  2. 02

    Challenger enters

    One model names 6 to 8 real treatments. Real names, real modalities. Invented compounds are a kill, not a feature.

  3. 03

    Critic at four gates

    The other model tries to kill every idea. Triage, mechanism, tractability, falsification. Most lines get struck.

  4. 04

    The ledger stays

    Survivors and wipeouts both go in the archive. You can open the record and click through to the public sources.

The machine
Open Targets
ClinicalTrials
PubMed

Three public sources. One pack. Both models see the same pages. Nothing invented in this step.

Challenger · Critic

One names 6 to 8 real treatments. The other tries to kill them at four gates.

01
Triage
02
Mechanism
03
Tractability
04
Falsification
01 Triage

Is it a real drug, a real trial, a real name? Made-up compounds die here.

02 Mechanism

Does the causal chain hold, or is it a slogan with a target glued on?

03 Tractability

Can anyone actually run this, or did a Phase 3 already bury it?

04 Falsification

What experiment would kill the idea? If there is none, the idea dies.

Latest finished cycle

thyroid

Wipeout. Every candidate for thyroid died. That is a real result.

Cycle 0004 · point means survived the gate · cross means killed there
Entered01020304
  • Lenvatinib
    killed · mechanism
  • Sorafenib
    killed · mechanism
  • Dabrafenib plus trametinib
    killed · mechanism
  • Selpercatinib
    killed · mechanism
  • Larotrectinib
    killed · mechanism
  • Pembrolizumab
    killed · mechanism
  • Metformin
    killed · mechanism
  • Methimazole
    killed · triage

0 standing · 8 crossed out

Open the record. Models, NCT ids, PMIDs, kill reasons.

Check it yourself

The tech is meant to be inspectable.

Open Targets

Disease id and target scores. The link goes to their page, not ours.

ClinicalTrials.gov

Every trial is an NCT. Click it and you leave Medbot.

PubMed

Every paper is a PMID. Same rule.

Named models

Challenger and critic are written on the record. Same pack for both.

Not a clinic

No recipes. No dosing. No claimed cure.

Medbot is literature and argument. Every finding stays UNREVIEWED until a human says otherwise. The useful output is the kill, and the reason.